Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-benzyl-N-methyldecan-1-amine and its derivative mitigate 2,4- dinitrobenzenesulfonic acid-induced colitis and collagen-induced rheumatoid arthritis. | Front Pharmacol | 2023 | 37153778 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens. | Science | 2023 | 37141313 | PubTator, text mining | PubMed |
| PKM2/STAT1-mediated PD-L1 upregulation on neutrophils during sepsis promotes neutrophil organ accumulation by serving an anti-apoptotic role. | J Inflamm (Lond) | 2023 | 37131151 | PubTator, text mining | PubMed |
| Role of tumor-associated macrophages in common digestive system malignant tumors. | World J Gastrointest Oncol | 2023 | 37123058 | PubTator, text mining | PubMed |
| DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer. | Biochim Biophys Acta Gene Regul Mech | 2023 | 37116859 | PubTator, text mining | PubMed |
| Prognostic role of plasma vitamin D and its association with disease characteristics in germ cell tumours. | Front Oncol | 2023 | 37114140 | PubTator, text mining | PubMed |
| mCrutch: A Novel m-Health Approach Supporting Continuity of Care. | Sensors (Basel) | 2023 | 37112492 | PubTator, text mining | PubMed |
| The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. | Pharmaceutics | 2023 | 37111592 | PubTator, text mining | PubMed |
| Canagliflozin Delays Aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK Pathway. | Antioxidants (Basel) | 2023 | 37107212 | PubTator, text mining | PubMed |
| MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approach. | Front Mol Biosci | 2023 | 37091863 | PubTator, text mining | PubMed |
| RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond. | Front Immunol | 2023 | 37090690 | PubTator, text mining | PubMed |
| From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors. | Front Chem | 2023 | 37090247 | PubTator, text mining | PubMed |
| The phosphoproteome of choroid plexus epithelial cells following infection with Neisseria meningitidis. | Front Cell Infect Microbiol | 2023 | 37065199 | PubTator, text mining | PubMed |
| Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer. | Int J Biol Sci | 2023 | 37063431 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer. | Front Pharmacol | 2023 | 37063293 | PubTator, text mining | PubMed |
| Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway. | J Biol Chem | 2023 | 37059179 | PubTator, text mining | PubMed |
| The biological responses of vitamin K2: A comprehensive review. | Food Sci Nutr | 2023 | 37051359 | PubTator, text mining | PubMed |
| Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. | Molecules | 2023 | 37049920 | PubTator, text mining | PubMed |
| High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37046731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=15